» Articles » PMID: 31611220

Incidence of Inflammatory Bowel Disease in Patients with Ankylosing Spondylitis

Overview
Journal Ann Rheum Dis
Specialty Rheumatology
Date 2019 Oct 16
PMID 31611220
Citations 6
Authors
Affiliations
Soon will be listed here.
Citing Articles

Ankylosing spondylitis: acute/subacute vs. chronic iridocyclitis - a bidirectional two-sample Mendelian randomization study.

Li H, Xu Y, Guo Q, Zhang T, Zhou S, Wu M Front Immunol. 2024; 14:1295118.

PMID: 38274819 PMC: 10808375. DOI: 10.3389/fimmu.2023.1295118.


Revealing mechanism of Methazolamide for treatment of ankylosing spondylitis based on network pharmacology and GSEA.

Sun T, Wang M, Liang W, Gao P, Liu Q, Yan X Sci Rep. 2023; 13(1):15370.

PMID: 37717047 PMC: 10505193. DOI: 10.1038/s41598-023-42721-x.


Seronegative spondyloarthropathy-associated inflammatory bowel disease.

Wang C, Tsai H World J Gastroenterol. 2023; 29(3):450-468.

PMID: 36688014 PMC: 9850936. DOI: 10.3748/wjg.v29.i3.450.


Spectrum of Spondyloarthritis Among Chinese Populations.

Zhang S, Peng L, Li Q, Zhao J, Xu D, Zhao J Curr Rheumatol Rep. 2022; 24(8):247-258.

PMID: 35829981 PMC: 9307523. DOI: 10.1007/s11926-022-01079-1.


Mechanism of Hip Arthropathy in Ankylosing Spondylitis: Abnormal Myeloperoxidase and Phagosome.

Yu C, Zhan X, Liang T, Chen L, Zhang Z, Jiang J Front Immunol. 2021; 12:572592.

PMID: 34880852 PMC: 8647161. DOI: 10.3389/fimmu.2021.572592.